Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain
Shearer, Arran T, Bagust, Adrian, Ampudia-Blasco, F Javier, Martínez-Lage Alvarez, Belén, Pérez Escolano, Isabel, París, Gonzalo
Published in PharmacoEconomics (2006)
Published in PharmacoEconomics (2006)
Get full text
Journal Article
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain: Modelling Life-Time Metabolic Progression and Cost-Effectiveness of Treatment Strategies for Type 2 Diabetes
SHEARER, Arran T, BAGUST, Adrian, AMPUDIA-BLASCO, F. Javier, MARTINEZ-LAGE ALVAREZ, Belen, PEREZ ESCOLANO, Isabel, PARIS, Gonzalo
Published in PharmacoEconomics (2006)
Get full text
Published in PharmacoEconomics (2006)
Journal Article